BioVaxys Technology Corp. BIOV.CN Stock
BioVaxys Technology Corp. Price Chart
BioVaxys Technology Corp. BIOV.CN Financial and Trading Overview
| BioVaxys Technology Corp. stock price | 0.08 CAD |
| Previous Close | 0.03 CAD |
| Open | 0 CAD |
| Bid | 0.03 CAD x N/A |
| Ask | 0.03 CAD x N/A |
| Day's Range | 0 - 0 CAD |
| 52 Week Range | 0 - 0.26 CAD |
| Volume | 0 CAD |
| Avg. Volume | 158.84K CAD |
| Market Cap | 4.35M CAD |
| Beta (5Y Monthly) | -0.237358 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.12 CAD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
BIOV.CN Valuation Measures
| Enterprise Value | 4.28M CAD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
BioVaxys Technology Corp. Stock Price History
| Beta (5Y Monthly) | -0.237358 |
| 52-Week Change | -72.72% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.26 CAD |
| 52 Week Low | 0 CAD |
| 50-Day Moving Average | 0.04 CAD |
| 200-Day Moving Average | 0.11 CAD |
BIOV.CN Share Statistics
| Avg. Volume (3 month) | 158.84K CAD |
| Avg. Daily Volume (10-Days) | 111.6K CAD |
| Shares Outstanding | 145.11M |
| Float | 118.75M |
| Short Ratio | 0.61 |
| % Held by Insiders | 18.94% |
| % Held by Institutions | 0% |
| Shares Short | 154.59K |
| Short % of Float | N/A |
| Short % of Shares Outstanding | 0.11% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 2:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | October 31, 2022 |
| Most Recent Quarter (mrq) | January 31, 2023 |
| Next Fiscal Year End | October 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -45.76% |
| Return on Equity (ttm) | -350.17% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -11472245 CAD |
| Diluted EPS (ttm) | -0.12 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 71.61K CAD |
| Total Cash Per Share (mrq) | 0 CAD |
| Total Debt (mrq) | 0 CAD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.592 |
| Book Value Per Share (mrq) | -0.005 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -1446362 CAD |
| Levered Free Cash Flow (ttm) | -1405100 CAD |
Profile of BioVaxys Technology Corp.
| Country | Canada |
| State | ON |
| City | Etobicoke |
| Address | 146 Thirtieth Street |
| ZIP | M8W 3C4 |
| Phone | 646 452 7054 |
| Website | https://biovaxys.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
BioVaxys Technology Corp., a clinical-stage immunotherapeutic company, engages in developing antiviral and anticancer vaccine platforms. It develops BVX-0320, a SARS-CoV-2 vaccine; BVX-1021, a vaccine for the strain of coronavirus that causes SARS1; and BVX-0918, a haptenized tumor cell vaccine for ovarian cancer, as well as CoviDTH, a novel diagnostic platform to identify a T-cell immune response to the presence of SARS-CoV-2. The company is also developing Papilocare for human papilloma virus (HPV)-dependent cervical lesions. It has a bioproduction agreement with WuXi Biologics Limited to produce SARS-CoV-2 s-proteins for BVX-0320 and CoviDTH; and research collaboration with The Ohio State University, Wexner School of Medicine for BVX-0320. BioVaxys Technology Corp. is based in Vancouver, Canada.
Q&A For BioVaxys Technology Corp. Stock
What is a current BIOV.CN stock price?
BioVaxys Technology Corp. BIOV.CN stock price today per share is 0.08 CAD.
How to purchase BioVaxys Technology Corp. stock?
You can buy BIOV.CN shares on the Canadian Sec exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for BioVaxys Technology Corp.?
The stock symbol or ticker of BioVaxys Technology Corp. is BIOV.CN.
Which industry does the BioVaxys Technology Corp. company belong to?
The BioVaxys Technology Corp. industry is Biotechnology.
How many shares does BioVaxys Technology Corp. have in circulation?
The max supply of BioVaxys Technology Corp. shares is 145.11M.
What is BioVaxys Technology Corp. Price to Earnings Ratio (PE Ratio)?
BioVaxys Technology Corp. PE Ratio is now.
What was BioVaxys Technology Corp. earnings per share over the trailing 12 months (TTM)?
BioVaxys Technology Corp. EPS is -0.12 CAD over the trailing 12 months.
Which sector does the BioVaxys Technology Corp. company belong to?
The BioVaxys Technology Corp. sector is Healthcare.